8-K Announcements
6Material company update
Apr 28, 2026·SEC
Material company update
Feb 5, 2026·SEC
Material company update
Dec 8, 2025·SEC
Omnicell, Inc.(OMCL)Earnings, Financials & Key Ratios
OMCL•NASDAQ
854.0× P/E·Price updated Jun 13, 2026
SectorHealthcareIndustryHealthcare ITSub-IndustryHealthcare Communications, Workforce and Supply Chain
AboutOmnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.Show more
- Revenue$1.18B+6.5%
- EBITDA$84M-6.8%
- Net Income$2M-83.6%
- EPS (Diluted)0.04-83.6%
- Gross Margin42.49%+0.3%
- EBITDA Margin7.09%-12.5%
- Operating Margin0.44%+1337.3%
- Net Margin0.17%-84.6%
- ROE0.17%-83.9%
- ROIC0.31%+1490.3%
- Debt/Equity0.17-46.1%
- Interest Coverage2.84+3709.3%
OMCL Key Insights
Omnicell, Inc. (OMCL) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong Piotroski F-Score: 7/9
- ✓High quality earnings: Operating CF exceeds net income
- ✓Trading at only 1.4x book value
✗Weaknesses
- ✗Profits declining 42.3% over 5 years
- ✗Thin 5Y average net margin of 1.4%
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when OMCL posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
OMCL Price & Volume
Omnicell, Inc. (OMCL) stock price & volume — 10-year historical chart
Loading chart...
OMCL Growth Metrics
Omnicell, Inc. (OMCL) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years9.35%
5 Years5.84%
3 Years-2.94%
TTM7.86%
Profit CAGR
10 Years-23.72%
5 Years-42.34%
3 Years-28.64%
TTM-3.55%
EPS CAGR
10 Years-25.49%
5 Years-43.06%
3 Years-28.26%
TTM-3.51%
Return on Capital
10 Years2.39%
5 Years1.1%
3 Years-0.23%
Last Year0.34%
OMCL Recent Earnings
Omnicell, Inc. (OMCL) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 11/12 qtrs (92%)●Beat Revenue 8/12 qtrs (67%)
Q2 2026Latest
Apr 28, 2026EPS
$0.55
Est $0.33
+66.7%
Revenue
$310M
Est $304M
+1.9%
Q1 2026
Feb 5, 2026EPS
$0.40
Est $0.47
-14.9%
Revenue
$314M
Est $313M
+0.2%
Q4 2025
Oct 30, 2025EPS
$0.51
Est $0.36
+41.7%
Revenue
$311M
Est $313M
-0.9%
Q3 2025
Jul 31, 2025EPS
$0.45
Est $0.31
+45.2%
Revenue
$291M
Est $292M
-0.5%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 28, 2026 | $0.55vs $0.33+66.7% | $310Mvs $304M+1.9% |
| Q1 2026 | Feb 5, 2026 | $0.40vs $0.47-14.9% | $314Mvs $313M+0.2% |
| Q4 2025 | Oct 30, 2025 | $0.51vs $0.36+41.7% | $311Mvs $313M-0.9% |
| Q3 2025 | Jul 31, 2025 | $0.45vs $0.31+45.2% | $291Mvs $292M-0.5% |
Based on last 12 quarters of dataView full earnings history →
OMCL Peer Comparison
Omnicell, Inc. (OMCL) competitors in Healthcare Communications, Workforce and Supply Chain — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 BDX | 52.98B | 146.24 | 25.08 | 8.23% | 5.33% | 4.54% | 0.76 | |
 HSIC | 9.32B | 81.25 | 24.85 | 4.03% | 3.02% | 8.24% | 0.77 | |
 MCK | 94.25B | 784.05 | 20.43 | 12.36% | 1.18% | |||
 CAH | 52.68B | 223.85 | 34.71 | -1.87% | 0.62% | |||
 VEEV | 25.92B | 159.54 | 29.33 | 16.34% | 28.37% | 13.36% | 0.01 | |
 HCAT | 136.7M | 1.85 | -0.73 | 1.48% | -87.69% | -99.78% | 0.70 | |
 AMZN | 2.57T | 238.55 | 33.27 | 12.38% | 12.22% | 23.34% | 0.37 | |
 MSFT | 2.9T | 390.74 | 28.65 | 14.93% | 39.34% | 33.13% | 0.33 |
Compare OMCL vs Peers
Omnicell, Inc. (OMCL) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
OMCL Income Statement
Omnicell, Inc. (OMCL) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 716.16M | 787.31M | 897.03M | 892.21M | 1.13B | 1.3B | 1.15B | 1.11B | 1.18B | 1.23B |
Revenue Growth % | 3.4% | 9.93% | 13.94% | -0.54% | 26.88% | 14.48% | -11.48% | -3.04% | 6.53% | 7.86% |
Cost of Goods Sold | 394.08M | 414.98M | 460.12M | 478.92M | 577.37M | 706.96M | 647.18M | 641.24M | 681.4M | 692.19M |
COGS % of Revenue | 55.03% | 52.71% | 51.29% | 53.68% | 51% | 54.55% | 56.42% | 57.65% | 57.51% | - |
Gross Profit | 322.09M▲ 0% | 372.33M▲ 15.6% | 436.91M▲ 17.3% | 413.29M▼ 5.4% | 554.65M▲ 34.2% | 588.99M▲ 6.2% | 499.93M▼ 15.1% | 471M▼ 5.8% | 503.44M▲ 6.9% | 532.87M▲ 0% |
Gross Margin % | 44.97% | 47.29% | 48.71% | 46.32% | 49% | 45.45% | 43.58% | 42.35% | 42.49% | 43.5% |
Gross Profit Growth % | 2.64% | 15.6% | 17.35% | -5.41% | 34.2% | 6.19% | -15.12% | -5.79% | 6.89% | - |
Operating Expenses | 316.33M | 327.94M | 358.56M | 377.77M | 465.15M | 591.31M | 519.26M | 470.67M | 498.28M | 499.24M |
OpEx % of Revenue | 44.17% | 41.65% | 39.97% | 42.34% | 41.09% | 45.63% | 45.27% | 42.32% | 42.05% | - |
Selling, General & Admin | 250.31M | 263.1M | 289.92M | 307.61M | 389.43M | 486.34M | 425.97M | 380.25M | 409.61M | 409.57M |
SG&A % of Revenue | 34.95% | 33.42% | 32.32% | 34.48% | 34.4% | 37.53% | 37.13% | 34.19% | 34.57% | - |
Research & Development | 66.02M | 64.84M | 68.64M | 70.16M | 75.72M | 104.97M | 93.29M | 90.41M | 88.67M | 89.67M |
R&D % of Revenue | 9.22% | 8.24% | 7.65% | 7.86% | 6.69% | 8.1% | 8.13% | 8.13% | 7.48% | - |
Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | 5.75M▲ 0% | 44.39M▲ 671.5% | 78.35M▲ 76.5% | 35.53M▼ 54.7% | 89.51M▲ 151.9% | -2.32M▼ 102.6% | -19.33M▼ 732.1% | 337K▲ 101.7% | 5.16M▲ 1431.2% | 33.63M▲ 0% |
Operating Margin % | 0.8% | 5.64% | 8.73% | 3.98% | 7.91% | -0.18% | -1.69% | 0.03% | 0.44% | 2.75% |
Operating Income Growth % | -11.22% | 671.5% | 76.5% | -54.66% | 151.95% | -102.6% | -732.07% | 101.74% | 1431.16% | - |
EBITDA | 57.27M | 95.74M | 142.47M | 107.12M | 174.44M | 96.85M | 76.23M | 90.09M | 83.95M | 111M |
EBITDA Margin % | 8% | 12.16% | 15.88% | 12.01% | 15.41% | 7.47% | 6.65% | 8.1% | 7.09% | 9.06% |
EBITDA Growth % | -11.69% | 67.19% | 48.81% | -24.81% | 62.84% | -44.48% | -21.29% | 18.19% | -6.81% | 9.94% |
D&A (Non-Cash Add-back) | 51.51M | 51.35M | 64.12M | 71.59M | 84.93M | 99.17M | 95.56M | 89.75M | 78.8M | 77.37M |
EBIT | 11.14M | 44.39M | 78.35M | 35.53M | 89.51M | -2.32M | -15.58M | 337K | 17.49M | 39.45M |
Net Interest Income | 0 | 0 | -5.8M | -2.1M | -22.39M | -130K | 14.76M | 20.38M | -6.17M | 5.26M |
Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 14.76M | 24.9M | 0 | 7.3M |
Interest Expense | 0 | 0 | 5.8M | 2.1M | 22.39M | 130K | 0 | 4.53M | 6.17M | 2.14M |
Other Income/Expense | -6.63M | -8.78M | -4.42M | -6.18M | -23.5M | -130K | -779K | 25.26M | 6.17M | 4.13M |
Pretax Income | -879K▲ 0% | 35.62M▲ 4151.9% | 73.93M▲ 107.6% | 29.35M▼ 60.3% | 66.01M▲ 124.9% | -2.45M▼ 103.7% | -20.11M▼ 719.7% | 25.59M▲ 227.3% | 11.32M▼ 55.7% | 37.76M▲ 0% |
Pretax Margin % | -0.12% | 4.52% | 8.24% | 3.29% | 5.83% | -0.19% | -1.75% | 2.3% | 0.96% | 3.08% |
Income Tax | -21.48M | -2.11M | 12.6M | -2.85M | -11.84M | -8.1M | 263K | 13.06M | 9.27M | 17.33M |
Effective Tax Rate % | 2444.14% | -5.93% | 17.04% | -9.69% | -17.94% | 330.25% | -1.31% | 51.04% | 81.88% | 45.89% |
Net Income | 20.61M▲ 0% | 37.73M▲ 83.1% | 61.34M▲ 62.6% | 32.19M▼ 47.5% | 77.85M▲ 141.8% | 5.65M▼ 92.7% | -20.37M▼ 460.7% | 12.53M▲ 161.5% | 2.05M▼ 83.6% | 20.43M▲ 0% |
Net Margin % | 2.88% | 4.79% | 6.84% | 3.61% | 6.88% | 0.44% | -1.78% | 1.13% | 0.17% | 1.67% |
Net Income Growth % | 3317.08% | 83.11% | 62.58% | -47.51% | 141.81% | -92.74% | -460.68% | 161.51% | -83.62% | -3.55% |
Net Income (Continuing) | 30.52M | 37.73M | 61.34M | 32.19M | 77.85M | 5.65M | -20.37M | 12.53M | 2.05M | 20.43M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | 0.79▲ 0% | 0.93▲ 17.7% | 1.43▲ 53.8% | 0.74▼ 48.3% | 1.62▲ 118.9% | 0.12▼ 92.6% | -0.45▼ 475.0% | 0.27▲ 160.0% | 0.04▼ 83.6% | 0.44▲ 0% |
EPS Growth % | 203.85% | 17.72% | 53.76% | -48.25% | 118.92% | -92.59% | -475% | 160% | -83.59% | -3.51% |
EPS (Basic) | 0.81 | 0.96 | 1.48 | 0.76 | 1.79 | 0.13 | -0.45 | 0.27 | 0.04 | - |
Diluted Shares Outstanding | 38.71M | 40.56M | 42.94M | 43.74M | 47.94M | 45.89M | 45.21M | 46.26M | 46.36M | 45.94M |
Basic Shares Outstanding | 37.48M | 39.24M | 41.46M | 42.58M | 43.48M | 44.4M | 45.21M | 46.05M | 45.97M | 45.32M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
OMCL Balance Sheet
Omnicell, Inc. (OMCL) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 367.12M | 397.13M | 483.24M | 829.41M | 780.7M | 881.81M | 927.57M | 815.49M | 680.07M | 722.3M |
Cash & Short-Term Investments | 32.42M | 67.19M | 136.98M | 496.17M | 359.72M | 341.85M | 467.97M | 381.68M | 196.52M | 239.22M |
Cash Only | 32.42M | 67.19M | 127.21M | 485.93M | 349.05M | 330.36M | 467.97M | 369.2M | 196.52M | 239.22M |
Short-Term Investments | 0 | 0 | 9.77M | 10.25M | 10.66M | 11.49M | 0 | 12.47M | 0 | 0 |
Accounts Receivable | 198.81M | 196.24M | 218.36M | 190.12M | 240.89M | 299.47M | 263.89M | 256.4M | 216.86M | 249.8M |
Days Sales Outstanding | 101.33 | 90.98 | 88.85 | 77.78 | 77.67 | 84.34 | 83.97 | 84.14 | 66.8 | 70.39 |
Inventory | 96.14M | 100.87M | 108.01M | 96.3M | 119.92M | 147.55M | 110.1M | 88.66M | 100.91M | 99.2M |
Days Inventory Outstanding | 89.04 | 88.72 | 85.68 | 73.39 | 75.81 | 76.18 | 62.09 | 50.47 | 54.05 | 54.49 |
Other Current Assets | 4.5M | 12.14M | 1.06M | 20.7M | 31.01M | 64.17M | 51.36M | 61.48M | 132.08M | 134.08M |
Total Non-Current Assets | 613.18M | 684.11M | 757.57M | 995.09M | 1.36B | 1.33B | 1.3B | 1.31B | 1.29B | 1.28B |
Property, Plant & Equipment | 42.59M | 51.5M | 110.38M | 114.19M | 119.69M | 132.01M | 133.59M | 138.3M | 144.48M | 144.45M |
Fixed Asset Turnover | 16.81x | 15.29x | 8.13x | 7.81x | 9.46x | 9.82x | 8.59x | 8.04x | 8.20x | 8.42x |
Goodwill | 337.75M | 335.89M | 336.54M | 499.31M | 738.9M | 734.27M | 735.81M | 734.73M | 737.95M | 737.29M |
Intangible Assets | 168.11M | 143.69M | 209.94M | 262.24M | 374.61M | 323.67M | 277.83M | 246.7M | 170.1M | 165.43M |
Long-Term Investments | 15.44M | 17.08M | 19.75M | 22.16M | 18.39M | 32.92M | 54.8M | 52.74M | 60.74M | 227.22M |
Other Non-Current Assets | 39.84M | 120.76M | 66.83M | 82.18M | 94.32M | 83.74M | 64.37M | 75.53M | 123.04M | 122.36M |
Total Assets | 980.3M▲ 0% | 1.08B▲ 10.3% | 1.24B▲ 14.8% | 1.82B▲ 47.0% | 2.14B▲ 17.4% | 2.21B▲ 3.2% | 2.23B▲ 0.7% | 2.12B▼ 4.8% | 1.97B▼ 6.9% | 2B▲ 0% |
Asset Turnover | 0.73x | 0.73x | 0.72x | 0.49x | 0.53x | 0.59x | 0.52x | 0.52x | 0.60x | 0.61x |
Asset Growth % | 4.83% | 10.3% | 14.76% | 47.04% | 17.43% | 3.19% | 0.73% | -4.76% | -6.89% | -35.53% |
Total Current Liabilities | 212.54M | 204.58M | 237M | 276.42M | 876.16M | 428.45M | 367.79M | 595.68M | 476.61M | 483.05M |
Accounts Payable | 48.29M | 38.04M | 46.38M | 40.31M | 71.51M | 63.39M | 45.03M | 51.78M | 43.99M | 58.34M |
Days Payables Outstanding | 44.73 | 33.46 | 36.79 | 30.72 | 45.21 | 32.73 | 25.39 | 29.48 | 23.56 | 29.96 |
Short-Term Debt | 15.21M | 0 | 0 | 0 | 488.15M | 0 | 0 | 174.32M | 11.96M | 0 |
Deferred Revenue (Current) | 86.1M | 81.83M | 94.9M | 125.2M | 152.11M | 187.21M | 132.28M | 201.98M | 171.86M | 784.44M |
Other Current Liabilities | 114.47M | 124.88M | 44.16M | 55.75M | 71.13M | 73.45M | 126.02M | 0 | 191.63M | 212.82M |
Current Ratio | 1.73x | 1.94x | 2.04x | 3.00x | 0.89x | 2.06x | 2.52x | 1.37x | 1.43x | 1.50x |
Quick Ratio | 1.28x | 1.45x | 1.58x | 2.65x | 0.75x | 1.71x | 2.22x | 1.22x | 1.22x | 1.29x |
Cash Conversion Cycle | 145.64 | 146.24 | 137.74 | 120.45 | 108.28 | 127.8 | 120.67 | 105.13 | 97.29 | 94.93 |
Total Non-Current Liabilities | 250.57M | 197.04M | 158.56M | 580.58M | 119.65M | 652.17M | 670.13M | 281.97M | 266.3M | 264.43M |
Long-Term Debt | 194.92M | 135.42M | 50M | 467.2M | 0 | 566.57M | 569.66M | 166.4M | 167.6M | 190.56M |
Capital Lease Obligations | 0 | 0 | 50.67M | 48.9M | 39.91M | 39.41M | 33.91M | 31.12M | 24.79M | 105.81M |
Deferred Tax Liabilities | 28.58M | 41.48M | 39.09M | 39.63M | 51.7M | 2.1M | 1.62M | 1.11M | 683K | 3.9M |
Other Non-Current Liabilities | 9.83M | 9.56M | 11.72M | 19.17M | 7.84M | 6.72M | 6.32M | 7.22M | 9.97M | 10.16M |
Total Liabilities | 463.11M | 401.63M | 395.56M | 857M | 995.81M | 1.08B | 1.04B | 877.65M | 742.91M | 747.48M |
Total Debt | 210.13M | 135.42M | 110.73M | 528.29M | 541.01M | 616.74M | 614.09M | 382.55M | 204.34M | 190.56M |
Net Debt | 177.7M | 68.22M | -16.48M | 42.37M | 191.96M | 286.38M | 146.12M | 13.35M | 7.83M | -48.66M |
Debt / Equity | 0.41x | 0.20x | 0.13x | 0.55x | 0.47x | 0.55x | 0.52x | 0.31x | 0.17x | 0.15x |
Debt / EBITDA | 3.67x | 1.41x | 0.78x | 4.93x | 3.10x | 6.37x | 8.06x | 4.25x | 2.43x | 1.72x |
Net Debt / EBITDA | 3.10x | 0.71x | -0.12x | 0.40x | 1.10x | 2.96x | 1.92x | 0.15x | 0.09x | -0.44x |
Interest Coverage | - | - | 13.50x | 16.94x | 4.00x | -17.87x | - | 0.07x | 2.84x | 18.41x |
Total Equity | 517.2M▲ 0% | 679.62M▲ 31.4% | 845.25M▲ 24.4% | 967.5M▲ 14.5% | 1.15B▲ 18.5% | 1.13B▼ 1.4% | 1.19B▲ 5.2% | 1.24B▲ 4.6% | 1.23B▼ 0.9% | 1.26B▲ 0% |
Equity Growth % | 19.83% | 31.4% | 24.37% | 14.46% | 18.52% | -1.44% | 5.2% | 4.57% | -0.92% | 3.25% |
Book Value per Share | 13.36 | 16.76 | 19.68 | 22.12 | 23.92 | 24.63 | 26.30 | 26.88 | 26.57 | 27.35 |
Total Shareholders' Equity | 517.2M | 679.62M | 845.25M | 967.5M | 1.15B | 1.13B | 1.19B | 1.24B | 1.23B | 1.26B |
Common Stock | 48K | 50K | 51K | 53K | 54K | 55K | 56K | 57K | 58K | 0 |
Retained Earnings | 122.58M | 197.45M | 258.79M | 290.72M | 368.57M | 390.73M | 370.36M | 382.89M | 384.94M | 0 |
Treasury Stock | -185.07M | -185.07M | -185.07M | -238.11M | -238.11M | -290.32M | -290.32M | -290.32M | -368.31M | 0 |
Accumulated OCI | -6.11M | -10.85M | -9.45M | -5.52M | -8.41M | -17.09M | -13.43M | -17.2M | -8.85M | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
OMCL Cash Flow Statement
Omnicell, Inc. (OMCL) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 24.83M | 103.97M | 145.01M | 185.87M | 231.81M | 77.78M | 181.09M | 187.72M | 127.3M | 155.88M |
Operating CF Margin % | 3.47% | 13.21% | 16.17% | 20.83% | 20.48% | 6% | 15.79% | 16.88% | 10.74% | - |
Operating CF Growth % | -48.19% | 318.64% | 39.48% | 28.18% | 24.72% | -66.45% | 132.83% | 3.66% | -32.19% | 61.2% |
Net Income | 20.61M | 37.73M | 61.34M | 32.19M | 77.85M | 5.65M | -20.37M | 12.53M | 2.05M | 20.43M |
Depreciation & Amortization | 51.51M | 51.35M | 64.12M | 71.59M | 106.98M | 99.17M | 95.56M | 89.75M | 86.63M | 83.32M |
Stock-Based Compensation | 21.86M | 28.89M | 34.05M | 44.7M | 53.16M | 68.25M | 55.3M | 39.32M | 44.5M | 31.24M |
Deferred Taxes | -26.84M | -5.71M | -1.34M | -6.55M | 0 | -37.32M | -11.05M | -14.86M | -1.29M | 6.77M |
Other Non-Cash Items | 2.11M | 2.42M | 2.65M | 6.63M | 50.42M | 15.5M | 17.98M | 2.64M | 3.74M | 17.46M |
Working Capital Changes | -44.41M | -10.72M | -15.81M | 37.3M | -56.6M | -73.47M | 43.67M | 58.33M | -8.33M | -3.35M |
Change in Receivables | -39.07M | -6.19M | -23.52M | 12.03M | -40.97M | -60.36M | 38.74M | -5M | 41.42M | 4.99M |
Change in Inventory | -26.84M | -6.76M | -8.12M | 12.36M | -25.7M | -30.11M | 38.02M | 5.39M | -11.22M | -7.04M |
Change in Payables | 19.71M | -9.15M | 7.89M | -6.3M | 0 | -7.75M | -17.52M | 7.21M | -9.28M | 5.96M |
Cash from Investing | -34.99M | -54.37M | -61.66M | -279.87M | -412.5M | -58.67M | -55.02M | -52.79M | -60.36M | -60.49M |
Capital Expenditures | -30.54M | -54.37M | -61.66M | -54.87M | -28.97M | -60.74M | -55.02M | -36.46M | -40.41M | -52.53M |
CapEx % of Revenue | 4.26% | 6.91% | 6.87% | 6.15% | 2.56% | 4.69% | 4.8% | 3.28% | 3.41% | 4.29% |
Acquisitions | -4.45M | 0 | 0 | -225M | -354.16M | 2.07M | 0 | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | -15.2M | 1.68M | 3.7M | -29.14M | -29.37M | 15.35M | 0 | -5.93M | -9.78M | -9.6M |
Cash from Financing | -9.88M | -13.6M | -23.48M | 456.27M | 47.36M | -20.95M | 23.42M | -235.58M | -218.32M | -219.96M |
Debt Issued (Net) | -43.5M | -77M | -90M | 509.67M | 0 | 0 | -2.97M | -225.46M | -175M | -175M |
Equity Issued (Net) | -5.89M | 39.57M | 37.81M | -61.77M | -16.29M | -52.21M | 23.22M | 38.58M | -60.73M | -61.24M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | -53.03M | -16.29M | -52.21M | 0 | 0 | -77.6M | -77.6M |
Other Financing | 39.52M | 23.84M | 28.71M | 8.38M | 63.65M | 31.26M | 3.17M | -48.7M | 17.41M | 16.27M |
Net Change in Cash | -22.06M▲ 0% | 34.77M▲ 257.6% | 60.02M▲ 72.6% | 362.71M▲ 504.3% | -134.3M▼ 137.0% | -2.79M▲ 97.9% | 148.14M▲ 5419.4% | -102.36M▼ 169.1% | -147.58M▼ 44.2% | -123.44M▲ 0% |
Free Cash Flow | -5.71M▲ 0% | 49.59M▲ 969.0% | 83.34M▲ 68.1% | 131M▲ 57.2% | 202.84M▲ 54.8% | 17.04M▼ 91.6% | 139.62M▲ 719.3% | 151.26M▲ 8.3% | 86.89M▼ 42.6% | 111.77M▲ 0% |
FCF Margin % | -0.8% | 6.3% | 9.29% | 14.68% | 17.92% | 1.31% | 12.17% | 13.6% | 7.33% | 9.12% |
FCF Growth % | -130.4% | 968.97% | 68.06% | 57.18% | 54.84% | -91.6% | 719.32% | 8.34% | -42.56% | -4.1% |
FCF per Share | -0.15 | 1.22 | 1.94 | 2.99 | 4.23 | 0.37 | 3.09 | 3.27 | 1.87 | 2.43 |
FCF Conversion (FCF/Net Income) | 1.21x | 2.76x | 2.36x | 5.77x | 2.98x | 13.77x | -8.89x | 14.98x | 62.04x | 5.47x |
Interest Paid | 6.55M | 7.49M | 3.58M | 522K | 1.92M | 1.44M | 0 | 1.62M | 0 | 0 |
Taxes Paid | 7.78M | 3.49M | 7.76M | 10.34M | 0 | 19M | 0 | 11.28M | 0 | 0 |
OMCL Key Ratios
Omnicell, Inc. (OMCL) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 4.34% | 6.3% | 8.04% | 3.55% | 7.36% | 0.5% | -1.76% | 1.03% | 0.17% | 1.64% |
| Return on Invested Capital (ROIC) | 0.65% | 4.62% | 7.45% | 2.9% | 5.72% | -0.13% | -1.05% | 0.02% | 0.31% | 2.04% |
| Gross Margin | 44.97% | 47.29% | 48.71% | 46.32% | 49% | 45.45% | 43.58% | 42.35% | 42.49% | 43.5% |
| Net Margin | 2.88% | 4.79% | 6.84% | 3.61% | 6.88% | 0.44% | -1.78% | 1.13% | 0.17% | 1.67% |
| Debt / Equity | 0.41x | 0.20x | 0.13x | 0.55x | 0.47x | 0.55x | 0.52x | 0.31x | 0.17x | 0.15x |
| Interest Coverage | - | - | 13.50x | 16.94x | 4.00x | -17.87x | - | 0.07x | 2.84x | 18.41x |
| FCF Conversion | 1.21x | 2.76x | 2.36x | 5.77x | 2.98x | 13.77x | -8.89x | 14.98x | 62.04x | 5.47x |
| Revenue Growth | 3.4% | 9.93% | 13.94% | -0.54% | 26.88% | 14.48% | -11.48% | -3.04% | 6.53% | 7.86% |
Related:OMCL Dividend History·OMCL Revenue History·OMCL Price History·OMCL P/E History·OMCL Financial Ratios·OMCL Institutional Holders
OMCL SEC Filings & Documents
Omnicell, Inc. (OMCL) SEC filings — annual & quarterly reports (10-K, 10-Q)
OMCL Frequently Asked Questions
Omnicell, Inc. (OMCL) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Omnicell, Inc. (OMCL) reported $1.23B in revenue for fiscal year 2025. This represents a 1719% increase from $67.4M in 2000.
Omnicell, Inc. (OMCL) grew revenue by 6.5% over the past year. This is steady growth.
Yes, Omnicell, Inc. (OMCL) is profitable, generating $20.4M in net income for fiscal year 2025 (0.2% net margin).
Dividend & Returns
Omnicell, Inc. (OMCL) has a return on equity (ROE) of 0.2%. This is below average, suggesting room for improvement.
Omnicell, Inc. (OMCL) generated $111.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.